Latest Funding News

Waratah Minerals reported a net cash outflow of AUD 3.4 million from operations in Q3 2025 but bolstered its liquidity with AUD 12.2 million raised through financing activities, ending the quarter with AUD 16.1 million in cash.

African Gold Limited reports robust September quarter results, confirming high-grade gold mineralisation at Blaffo Guetto and advancing exploration at Konahiri North, backed by a $16 million cash boost from a profitable Montage share sale.

Asian Battery Metals PLC advances its flagship Oval Cu-Ni-PGE discovery with Phase 3 drilling confirming mineralisation extensions and strong copper recoveries, while expanding its portfolio through a strategic option on the Maikhan Uul Cu-Au project.

Brockman Mining Limited reports steady progress on its Marillana and Ophthalmia iron ore projects through joint ventures and infrastructure planning, maintaining a solid cash position despite no production this quarter.

Pure Resources has completed the acquisition of the Garnet Hills mining lease and confirmed high-grade garnet products through metallurgical testing, positioning itself for feasibility studies and U.S. partnerships.

Omnia Metals Group has completed its initial drilling at the Salt Creek Project with valuable geological insights, while securing a 50/50 joint venture over the promising Corvette Project and raising $1.58 million to fuel exploration and US acquisitions.

Krakatoa Resources has launched a major drilling campaign at its Zopkhito Antimony-Gold Project in Georgia, backed by a $3.1 million capital raise, while also expanding its rare earths landholding in Western Australia.

Leeuwin Metals reports promising high-grade gold intersections at its Evanston prospect, completing a 5,000m drill program with 31 assays pending, and secures $5.8 million to accelerate exploration at its Marda Gold Project.

Far East Gold reports a productive September quarter with significant drilling results at its Idenburg Project, including a new high-grade discovery at North Bermol and an expanded pipeline of exploration targets.

Vectus Biosystems has signed a binding agreement to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its lead drug VB0004 and others, particularly in China.

Hammer Metals reports promising gold mineralisation at its Yandal Gold Project and defines fresh copper-gold targets at Mount Isa, with multiple funded drilling programs underway.

Elixinol Wellness Limited (ASX – EXL) has launched a substantial options offer to placement investors and its lead manager, pending shareholder approval. The offer could reshape the company’s capital structure and potentially raise $4.4 million upon exercise.